A hybrid vector system expands adeno-associated viral vector packaging capacity in a transgene-independent manner

Molecular Therapy

Volumn 16, Issue 1, 2008, Pages 124-130

  Ghosh, Arkasubhra ^a   Yue, Yongping ^a   Lai, Yi ^a   Duan, Dongsheng ^a  

^a University of Missouri   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; BETA GALACTOSIDASE; DYSTROPHIN; OVERLAPPING VECTOR; PARVOVIRUS VECTOR; TRANSSPLICING VECTOR; UNCLASSIFIED DRUG; VIRUS VECTOR;

ADENO ASSOCIATED VIRUS; AMINO ACID SEQUENCE; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; EXON; EXPRESSION VECTOR; GENE INSERTION; GENETIC RECOMBINATION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; PROTEIN DOMAIN; RNA SPLICING; SOUTHERN BLOTTING; VIRAL GENE DELIVERY SYSTEM; VIRUS HYBRID;

ADENO-ASSOCIATED VIRUS;

EID: 37549053613     PISSN: 15250016     EISSN: 15250024     Source Type: Journal    
DOI: 10.1038/sj.mt.6300322     Document Type: Article

References (31)

1. Zhang, L, Wang, D, Fischer, H, Fan, PD, Widdicombe, JH, Kan, YW et al. (1998). Efficient expression of CFTR function with adeno-associated virus vectors that carry shortened CFTR genes. Proc Natl Acad Sci USA 95: 10158-10163.
2. Wang, B, Li, J and Xiao, X (2000). Adeno-associated virus vector carrying human minidystrophin genes effectively ameliorates muscular dystrophy in mdx mouse model. Proc Natl Acad Sci USA 97: 13714-13719.
3. Harper, SQ, Hauser, MA, DelloRusso, C, Duan, D, Crawford, RW, Phelps, SF et al. (2002). Modular flexibility of dystrophin: Implications for gene therapy of Duchenne muscular dystrophy. Nat Med 8: 253-261.
4. Ostedgaard, LS, Zabner, J, Vermeer, DW, Rokhlina, T, Karp, PH, Stecenko, AA et al. (2002). CFTR with a partially deleted R domain corrects the cystic fibrosis chloride transport defect in human airway epithelia in vitro and in mouse nasal mucosa in vivo. Proc Natl Acad Sci USA 99: 3093-3098.
5. Fischer, AC, Smith, CI, Cebotaru, L, Zhang, X, Askin, FB, Wright, J et al. (2007). Expression of a truncated cystic fibrosis transmembrane conductance regulator with an AAV5-pseudotyped vector in primates. Mol Ther 15: 756-763.
6. Flotte, TR, Afione, SA, Solow, R, Drumm, ML, Markakis, D, Guggino, WB et al. (1993). Expression of the cystic fibrosis transmembrane conductance regulator from a novel adeno-associated virus promoter. J Biol Chem 268: 3781-3790.
7. Ostedgaard, LS, Rokhlina, T, Karp, PH, Lashmit, P, Afione, S, Schmidt, M et al. (2005). A shortened adeno-associated virus expression cassette for CFTR gene transfer to cystic fibrosis airway epithelia. Proc Natl Acad Sci USA 102: 2952-2957.
8. Duan, D, Yan, Z and Engelhardt, JF (2006). Expanding the capacity of AAV vectors. In: Bloom, ME, Cotmore, SF, Linden, RM, Parrish, CR and Kerr, JR (eds). Parvoviruses. Hodder Arnold; Distributed in the USA by Oxford University Press: London, New York. pp. 525-532.
9. Duan, D, Yue, Y, Yan, Z and Engelhardt, JF (2000). A new dual-vector approach to enhance recombinant adeno-associated virus-mediated gene expression through intermolecular cis activation. Nat Med 6: 595-598.
10. Yan, Z, Zhang, Y, Duan, D and Engelhardt, JF (2000). From the cover: trans-splicing vectors expand the utility of adeno-associated virus for gene therapy. Proc Natl Acad Sci USA 97: 6716-6721.
11. Sun, L, Li, J and Xiao, X (2000). Overcoming adeno-associated virus vector size limitation through viral DNA heterodimerization. Nat Med 6: 599-602.
12. Nakai, H, Storm, TA and Kay, MA (2000). Increasing the size of rAAV-mediated expression cassettes in vivo by intermolecular joining of two complementary vectors. Nat Biotechnol 18: 527-532.
13. Duan, D, Yue, Y and Engelhardt, JF (2001). Expanding AAV packaging capacity with trans-splicing or overlapping vectors: A quantitative comparison. Mol Ther 4: 383-391.
14. Halbert, CL, Allen, JM and Miller, AD (2002). Efficient mouse airway transduction following recombination between AAV vectors carrying parts of a larger gene. Nat Biotechnol 20: 697-701.
15. Reich, SJ, Auricchio, A, Hildinger, M, Glover, E, Maguire, AM, Wilson, JM et al. (2003). Efficient trans-splicing in the retina expands the utility of adeno-associated virus as a vector for gene therapy. Hum Gene Ther 14: 37-44.
16. Ghosh, A, Yue, Y and Duan, D (2006). Viral serotype and the transgene sequence influence overlapping adeno-associated viral (AAV) vector-mediated gene transfer in skeletal muscle. J Gene Med 8 298-305.
17. Yan, Z, Zak, R, Zhang, Y and Engelhardt JF (2005). Inverted terminal repeat sequences are important for intermolecular recombination and circularization of adeno-associated virus genomes. J Virol 79 364-379.
18. Yan, Z, Lei-Butters, DC, Zhang, Y, Zak, R and Engelhardt, JF (2007). Hybrid adeno-associated virus bearing nonhomologous inverted terminal repeats enhances dual-vector reconstruction of minigenes in vivo. Hum Gene Their 18: 81-87.
19. Xu, Z, Yue, Y, Lai, Y, Ye, C, Qiu, J, Pintel, DJ et al. (2004). Trans-splicing adeno-associated viral vector-mediated gene therapy is limited by the accumulation of spliced mRNA but not by dual vector coinfection efficiency. Hum Gene Ther 15: 896-905.
20. Lai, Y, Yue, Y, Liu, M, Ghosh, A, Engelhardt, JF, Chamberlain, JS et al. (2005). Efficient in vivo gene expression by trans-splicing adeno-associated viral vectors. Nat Biotechnol 23: 1435-1439.
21. Lai, Y, Yue, Y, Liu, M and Duan, D (2006). Synthetic intron improves transduction efficiency of trans-splicing adeno-associated viral vectors. Hum Gene Ther 17: 1036-1042.
22. Wang, Z, Ma, HI, Li, J, Sun, L, Zhang, J and Xiao, X (2003). Rapid and highly efficient transduction by double-stranded adeno-associated virus vectors in vitro and in vivo. Gene Ther 10: 2105-2111.
23. McCarty, DM, Fu, H, Monahan, PE, Toulson, CE, Naik, P and Somulski, RJ (2003). Adeno-associated virus terminal repeat (TR) mutant generates self-complementary vectors to overcome the rate-limiting step to transduction in vivo. Gene Ther 10: 2112-2118.
24. Fu, H, Muenzer, J, Samulski, RJ, Breese, G, Sifford, J, Zeng, X et al. (2003). Self-complementary adeno-associated virus serotype 2 vector: Global distribution and broad dispersion of AAV-mediated transgene expression in mouse brain. Mol Ther 8: 911-917.
25. Sironi, M, Pozzoli, U, Cagliani, R, Comi, GP, Bardoni, A and Bresolin, N (2001). Analysis of splicing parameters in the dystrophin gene: relevance for physiological and pathogenetic splicing mechanisms. Hum Genet 109: 73-84.
26. Flotte, TR (2007). Gene therapy: The first two decades and the current state-of-the-art. J Cell Physiol 213: 301-305.
27. Yue, Y and Duan, D (2002). Development of multiple cloning site cis-vectors for recombinant adeno-associated virus production. Biotechniques 33: 672, 674, 676-678.
28. Duan, D, Yan, Z, Yue, Y, Ding, W and Engelhardt JF (2001). Enhancement of muscle gene delivery with pseudotyped AAV-5 correlates with myoblast differentiation. J Virol 75: 7662-7671.
29. Duan, D, Yue, Y and Engelhardt, JF (2003). Consequences of DNA-dependent protein kinase catalytic subunit deficiency on recombinant adeno-associated virus genome circularization and heterodimerization in muscle tissue. J Virol 77: 4751-4759.
30. Duan, D, Sharma, P, Yang, J, Yue, Y, Dudus, L, Zhang, Y et al. (1998). Circular intermediates of recombinant adeno-associated virus have defined structural characteristics responsible for long term episomal persistence in muscle. J Virol 72: 8568-8577.
31. Yue, Y, Li, Z, Harper, SQ, Davisson, RL, Chamberlain, JS and Duan, D (2003). Microdystrophin gene therapy of cardiomyopathy restores dystrophin-glycoprotein complex and improves sarcolemma integrity in the mdx mouse heart. Circulation 108: 1626-1632.